The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest advances in diagnosing and treating dementia, epilepsy, movement disorders, myasthenia gravis, and other brain disorders. The three-day hybrid AAN Fall Conference took place at Caesars Palace in Las Vegas from Oct. 28 to 30, 2022. The digital on-demand content will be available in the Online Learning Center from Nov. 14, 2022, until Aug. 1, 2023.
Click above for a wrap-up of all the conference highlights.
The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest advances in diagnosing and treating dementia, epilepsy, movement disorders, myasthenia gravis, and other brain disorders. The three-day hybrid AAN Fall Conference took place at Caesars Palace in Las Vegas from Oct. 28 to 30, 2022. The digital on-demand content will be available in the Online Learning Center from Nov. 14, 2022, until Aug. 1, 2023.
Click above for a wrap-up of all the conference highlights.
The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest advances in diagnosing and treating dementia, epilepsy, movement disorders, myasthenia gravis, and other brain disorders. The three-day hybrid AAN Fall Conference took place at Caesars Palace in Las Vegas from Oct. 28 to 30, 2022. The digital on-demand content will be available in the Online Learning Center from Nov. 14, 2022, until Aug. 1, 2023.
Click above for a wrap-up of all the conference highlights.
Impact of the COVID-19 pandemic on Patients with Myasthenia Gravis: A survey of the Myasthenia Gravis Foundation of America MG Patient Registry - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36324261/
COVID-19 affected MG patients increasingly through the early pandemic. While face-to-face contact with a COVID-19 infected individual was an obvious risk factor, MG patients who had more people in the...
Discussion: COVID-19 affected MG patients increasingly through the early pandemic. While face-to-face contact with a COVID-19 infected individual was an obvious risk factor, MG patients who had more people in the household and unstable disease were at elevated risk for COVID-19 infection.
Tailoring Two Chemometric Models for Determination of Three Neuromuscular Combined Medications and Application to Spiked Human Plasma
AbstractBackground. Prednisolone, 6-mercaptopurine and pyridostigmine bromide are co-administered together to treat a neuromuscular autoimmune disease called my
/>
Conclusions: The developed models succeeded to predict the proposed drugs in their tertiary combinations and spiked human plasma with satisfied precision, accuracy, and good greenness behavior.



